WQ
TVRD

Wealth Quarterback’s Tvardi Therapeutics TVRD Stock Holding History

Wealth Quarterback’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$5K Hold
8
– – ﹤0.01% 605
2021
Q2 		$5K Buy
+8
New +$5.07K ﹤0.01% 620
2020
Q2 		– Sell
-8
Closed -$3.71K – 823
2020
Q1 		$3.71K Hold
8
– – ﹤0.01% 661
2019
Q4 		$4.53K Buy
+8
New +$5.61K ﹤0.01% 648

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Wealth Quarterback's TVRD Position: Q3 2021 in Review

Wealth Quarterback held its Tvardi Therapeutics (TVRD) position steady in Q3 2021 at 8 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #605.

Wealth Quarterback first reported a position in TVRD in Q4 2019 and has held it in 4 quarters since. 168 funds tracked by Wall St. Rank hold TVRD as of Q3 2021.

  • Wealth Quarterback held 8 shares of Tvardi Therapeutics worth $5K as of Q3 2021.
  • Wealth Quarterback left its Tvardi Therapeutics share count unchanged in Q3 2021.
  • Tvardi Therapeutics made up ﹤0.01% of Wealth Quarterback's portfolio in Q3 2021, its #605 holding.
  • Wealth Quarterback first reported a position in Tvardi Therapeutics in Q4 2019 and has held it in 4 quarters since.
  • 168 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.